Elimination of hepatitis B and C in Syria (National program)
Virus targets
Hepatitis B
Hepatitis C
Type
Testing and treatment implementation
Setting
National
Phase
Active
Health outcomes
Incidence
Mortality
Prevalence
WHO region
Eastern Mediterranean Region
Country
Syrian Arab Republic
Key interventions
Blood safety
Hepatitis B Vaccination
Injection safety and infection control
Strategic data analysis
Screening and diagnosis
Treatment (direct or referral)
Target population
Adolescents (10 - 19 years of age)
Adults
All ages
Blood transfusion recipients
Children (> one year < 10 years of age)
Children 12-17
Children 5-11
Children Under 5
Infants (less than one year of age)
Men who have sex with men
Newborns
Occupations with possible exposure
Sexual contact(s)
Performance target
Blood safety
Care cascade: HBV diagnosis
Care cascade: HBV testing
Care cascade: HBV treatment
Care cascade: HCV diagnosis
Care cascade: HCV testing
Care cascade: HCV treatment
Hepatitis B vaccination coverage
Summary and objectives
Objectives:
- Elimination of new infections and transmission among Syrian population by 2030
- Reduction of chronic hepatitis infections among the population by 90% of 2017 level
- Reduction of deaths from chronic hepatitis among the entire population by three fold
Challenges: Shortage in PCR test and the price is very expensive